(Q41293419)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8984675%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

review article

1 reference

title

Experimental immunotherapies for multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8984675%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8984675%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

author name string

H McFarland

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8984675%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8984675%20AND%20SRC:MED&resulttype=core&format=json

Seminars in Immunopathology

22 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8984675%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8984675%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8984675%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

1-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8984675%20AND%20SRC:MED&resulttype=core&format=json

Chronologic localization of myelin-reactive cells in the lesions of relapsing EAE: implications for the study of multiple sclerosis

22 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF00792605

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00792605

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00792605

Myelin basic protein‐specific T lymphocyte lines from MS patients and healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00792605

Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats

21 January 2018

1 reference

12 December 2020

Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1

1 reference

12 December 2020

Encephalitogenic epitopes of myelin basic protein

1 reference

12 December 2020

Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis

1 reference

12 December 2020

Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides

1 reference

12 December 2020

Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis

1 reference

12 December 2020

Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

1 reference

12 December 2020

Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

1 reference

12 December 2020

Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-1 alpha

1 reference

12 December 2020

Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system

1 reference

12 December 2020

The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells

1 reference

12 December 2020

Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.

1 reference

12 December 2020

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

1 reference

12 December 2020

MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination

1 reference

12 December 2020

Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes

1 reference

12 December 2020

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

1 reference

12 December 2020

Characterization of measles virus-induced cellular autoimmune reactions against myelin basic protein in Lewis rats

1 reference

12 December 2020

T-lymphocyte entry into the central nervous system

1 reference

12 December 2020

Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands

1 reference

12 December 2020

Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination

1 reference

12 December 2020

Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein

1 reference

12 December 2020

Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells

1 reference

12 December 2020

Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity

1 reference

12 December 2020

Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein

1 reference

12 December 2020

Theiler's Virus-Induced Demyelination: Prevention by Immunosuppression

1 reference

12 December 2020

In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis

1 reference

12 December 2020

Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course

1 reference

12 December 2020

Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen–Ia complex

1 reference

12 December 2020

Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis

1 reference

12 December 2020

Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis

1 reference

12 December 2020

Dominance and crypticity of T cell antigenic determinants

1 reference

12 December 2020

Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis

1 reference

12 December 2020

Amelioration of Autoimmune Encephalomyelitis by Myelin Basic Protein Synthetic Peptide-Induced Anergy

1 reference

12 December 2020

Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells.

1 reference

12 December 2020

Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery

1 reference

12 December 2020

Myelin in multiple sclerosis is developmentally immature

1 reference

12 December 2020

Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition

1 reference

12 December 2020

A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis

1 reference

12 December 2020

Diverse T cell receptor V beta gene usage in the central nervous system in experimental allergic encephalomyelitis

1 reference

12 December 2020

Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules

1 reference

12 December 2020

Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106

1 reference

12 December 2020

Effect of cloned interferon-gamma on expression of H-2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin

1 reference

12 December 2020

TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines

1 reference

12 December 2020

The major histocompatibility complex influences myelin basic protein 63-88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis

1 reference

12 December 2020

T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis

1 reference

12 December 2020

Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies

1 reference

12 December 2020

Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein

1 reference

12 December 2020

T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes.

1 reference

12 December 2020

Stimulation or tolerization of an anti-myelin basic protein T lymphocyte line with membrane fragments from antigen presenting cells

1 reference

12 December 2020

Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides

1 reference

12 December 2020

Heterogeneity of T-cell receptor alpha-chain complementarity-determining region 3 in myelin basic protein-specific T cells increases with severity of multiple sclerosis.

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma

1 reference

12 December 2020

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

1 reference

12 December 2020

Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats

1 reference

12 December 2020

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

12 December 2020

Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy

1 reference

12 December 2020

Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker

1 reference

12 December 2020

Immunological tolerance to a defined myelin basic protein antigen administered intrathymically

1 reference

12 December 2020

A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire

1 reference

12 December 2020

Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction

1 reference

12 December 2020

T cell receptor beta chain usage in myelin basic protein-specific rat T lymphocytes

1 reference

12 December 2020

Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells

1 reference

12 December 2020

Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors specific for myelin basic protein

1 reference

12 December 2020

In healthy primates, circulating autoreactive T cells mediate autoimmune disease

1 reference

12 December 2020

Copolymer-1-induced inhibition of antigen-specific T cell activation: interference with antigen presentation

1 reference

12 December 2020

Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma

1 reference

12 December 2020

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

1 reference

12 December 2020

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

1 reference

12 December 2020

Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance

1 reference

12 December 2020

Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins

1 reference

12 December 2020

Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.

1 reference

12 December 2020

Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity

1 reference

12 December 2020

Expression of vascular addressins and ICAM-1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse

1 reference

12 December 2020

Immunological aspects of demyelinating diseases

1 reference

12 December 2020

Major histocompatibility complex-linked control of the murine immune response to myelin basic protein.

1 reference

12 December 2020

Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness

1 reference

12 December 2020

Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis

1 reference

12 December 2020

Correlation between susceptibility to demyelination and interferon-gamma induction of major histocompatibility complex class II antigens on murine cerebrovascular endothelial cells

1 reference

12 December 2020

Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

1 reference

12 December 2020

Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis

1 reference

12 December 2020

A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis

1 reference

12 December 2020

Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals

1 reference

12 December 2020

Selective and nonselective stages in homing of T lymphocytes to the central nervous system during experimental allergic encephalomyelitis.

1 reference

12 December 2020

Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice

1 reference

12 December 2020

The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease

1 reference

12 December 2020

Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1

1 reference

12 December 2020

Overview of azathioprine treatment in multiple sclerosis

1 reference

12 December 2020

Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor

1 reference

12 December 2020

Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols

1 reference

12 December 2020

Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis

1 reference

12 December 2020

Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis

1 reference

12 December 2020

On the immunopathology of plaque development and repair in multiple sclerosis

1 reference

12 December 2020

Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells

1 reference

12 December 2020

A synthetic peptide from the third hypervariable region of major histocompatibility complex class II beta chain as a vaccine for treatment of experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system

1 reference

12 December 2020

Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations

1 reference

12 December 2020

Protection from experimental allergic encephalomyelitis by application of a bacterial superantigen

1 reference

12 December 2020

Superantigen modulation of experimental allergic encephalomyelitis: activation of anergy determines outcome

1 reference

12 December 2020

Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.

1 reference

12 December 2020

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.

1 reference

12 December 2020

Analysis of V beta 8-CDR3 sequences derived from central nervous system of Lewis rats with experimental autoimmune encephalomyelitis.

1 reference

12 December 2020

Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL

1 reference

12 December 2020

Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis

1 reference

12 December 2020

Inducible expression of H-2 and Ia antigens on brain cells

1 reference

12 December 2020

Isolation of myelin basic protein-reactive T-cell lines from normal human blood

1 reference

12 December 2020

Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes

1 reference

12 December 2020

Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis

1 reference

12 December 2020

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1 reference

12 December 2020

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering

1 reference

12 December 2020

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

1 reference

12 December 2020

Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: Implications for clinical trials and natural history

1 reference

12 December 2020

Pentoxifylline inhibits experimental allergic encephalomyelitis

1 reference

12 December 2020

T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis

1 reference

12 December 2020

Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides

1 reference

12 December 2020

Interleukin-10 prevents experimental allergic encephalomyelitis in rats.

1 reference

12 December 2020

High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice

1 reference

12 December 2020

Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion

1 reference

12 December 2020

Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized

1 reference

12 December 2020

Antigen‐driven tissue‐specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid protein‐induced experimental autoimmune encephalomyelitis in the SJL mouse

1 reference

12 December 2020

Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype

1 reference

12 December 2020

T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis

1 reference

12 December 2020

Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production

1 reference

12 December 2020

Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions.

1 reference

12 December 2020

Trials of vaccination against experimental autoimmune uveoretinitis with a T-cell receptor peptide

1 reference

12 December 2020

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

1 reference

12 December 2020

Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes

1 reference

12 December 2020

Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats

1 reference

12 December 2020

Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein

1 reference

12 December 2020

Endothelial cell expression of the intercellular adhesion molecule-1 (ICAM-1) in the central nervous system of guinea pigs during acute and chronic relapsing experimental allergic encephalomyelitis.

1 reference

12 December 2020

Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice

1 reference

12 December 2020

Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia.

1 reference

12 December 2020

Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor

1 reference

12 December 2020

Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention

1 reference

12 December 2020

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis

1 reference

12 December 2020

Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic V beta 5.2 and V beta 6.1 CDR2 peptides.

1 reference

12 December 2020

Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen

1 reference

12 December 2020

Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human "naive" and "memory" CD4+ T cells

1 reference

12 December 2020

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

12 December 2020

Apoptotic elimination of V beta 8.2+ cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of V beta 8.2+ encephalitogenic T cells

1 reference

12 December 2020

Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1

1 reference

12 December 2020

Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis

1 reference

12 December 2020

Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain.

1 reference

12 December 2020

A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

1 reference

12 December 2020

Human cytotoxic T-cell recognition of a synthetic peptide of myelin basic protein

1 reference

12 December 2020

Mapping T-cell receptor–peptide contacts by variant peptide immunization of single-chain transgenics

1 reference

12 December 2020

Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of V beta 5.2 and V beta 6.1 CDR2 peptides

1 reference

12 December 2020

Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 2

1 reference

12 December 2020

https://api.fatcat.wiki/v0/release/lxenorw4jzadpklhz3bjtpcewe

Identifiers

1 reference

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_lxenorw4jzadpklhz3bjtpcewe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lxenorw4jzadpklhz3bjtpcewe

30 July 2022

mapped directly with Wikidata item

PMC publication ID

7087544

0 references

https://api.fatcat.wiki/v0/release/lxenorw4jzadpklhz3bjtpcewe

1 reference

30 July 2022